
Xencor rose 180.9% from $13.74 to a 1-year high of $38.59, ahead of the S&P 500's +10.0%. Its worst day was Mar 5 (−12.4%), and its low came May 19 at $10.41.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.09 beat the $-0.61 estimate on $28.2M revenue (est. $26.6M).
+13.1% · S&P 500 −0.6%
EPS of $-1.71 missed the $-0.73 estimate on $4.5M revenue (est. $25.0M).
Story events cover the past 12 months · Times ET
−5.4% · S&P 500 −0.3%
Xencor closed at its lowest level of the year, 24.2% below where the year started.
−5.9% · S&P 500 −0.7%
Xencor shares rose 10.8%, while the S&P 500 fell 0.3%.
+10.8% · S&P 500 −0.3%
Details of the Proffered Paper Oral PresentationTitle: Phase 1 results of XmAb819, a novel ENPP3 x CD3 bispecific, in advanced clear cell renal cell carcinoma (ccRCC)Presenter: Sumanta Pal, M.D., FASCO, Professor and
+16.9%, the year's best day · S&P 500 −1.0%
EPS of $-0.29 beat the $-0.83 estimate on $51.2M revenue (est. $17.2M).
+0.8% · S&P 500 −0.2%
Xencor shares rose 15.9%, while the S&P 500 rose 0.7%.
+15.9%, on 9M shares, the year's heaviest volume · S&P 500 +0.7%
EPS of $0.50 beat the $-0.34 estimate on $116.5M revenue (est. $63.6M).
−2.8% · S&P 500 −4.4%
Where it ended: a 1-year high close of $38.59 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $-0.96, revenue est. $32.1M).
Nothing in the past 12 months.
All XNCR dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XNCR and SPY from Benzinga historical bars. Not investment advice.